๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

344 PRECLINICAL PROFILES OF IDX136 AND IDX316, TWO NOVEL MACROCYCLIC HCV PROTEASE INHIBITORS

โœ Scribed by L.B. Lallos; J.P. Bilello; M.A. Soubasakos; J. Gillum; M. La Colla; M. Liuzzi; J. Mc Carville; M. Seifer; S.S. Good; M. Larsson; J. Selden; C. Parsy; D. Surleraux; D.N. Standring

Book ID
117377353
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
50 KB
Volume
50
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Design and synthesis of novel fluoro ami
Design and synthesis of novel fluoro amino acids: synthons for potent macrocyclic HCV NS3 protease inhibitors
โœ Latha G. Nair; Stephane Bogen; Frank Bennett; Kevin Chen; Bancha Vibulbhan; Yuhu ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› Elsevier Science ๐ŸŒ French โš– 952 KB

The Hepatitis C Virus (HCV) is a major health hazard and its infection is a leading cause of chronic liver disease world wide. In our efforts toward the discovery of a back up to our first clinical candidate, Boceprevir (SCH 503034), we approached the depeptidization of the molecule through macrocyc